COSMOS Pharmaceutical Corporation (TYO:3349)
Japan
· Delayed Price · Currency is JPY 6,846.00
+335.00 (5.15%)
At close: Mar 9, 2026
COSMOS Pharmaceutical Revenue
COSMOS Pharmaceutical had revenue of 264.78B JPY in the quarter ending November 30, 2025, with 8.47% growth. This brings the company's revenue in the last twelve months to 1.04T, up 4.84% year-over-year. In the fiscal year ending May 31, 2025, COSMOS Pharmaceutical had annual revenue of 1.01T with 4.81% growth.
Revenue (ttm)
1,042.63B
Revenue Growth
+4.84%
P/S Ratio
0.52
Revenue / Employee
182.63M
Employees
5,709
Market Cap
542.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 1,011.39B | 46.40B | 4.81% |
| May 31, 2024 | 964.99B | 137.29B | 16.59% |
| May 31, 2023 | 827.70B | 72.28B | 9.57% |
| May 31, 2022 | 755.41B | 28.99B | 3.99% |
| May 31, 2021 | 726.42B | 42.02B | 6.14% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sundrug | 833.92B |
| Sugi Holdings | 993.53B |
| Kusuri No Aoki Holdings | 538.45B |
| MatsukiyoCocokara & Co. | 1,099.45B |
| Tsuruha Holdings | 1,014.72B |
| Create SD Holdings | 474.21B |
| Ain Holdings | 541.80B |
| Genky DrugStores | 211.29B |